Every lot published · search any lot number before you order

Retatrutide 1 mg: What the Phase 2 Arm Found

The Phase 2 paper reported an estimated mean weight change of −8.7% at 48 weeks in the 1 mg retatrutide group, compared with −2.1% in the shared placebo group.

Retatrutide 1 mg: What the Phase 2 Arm Found. The lowest Phase 2 target group. Assigned amount, Trial protocol, Group result. GLP LIFE SCIENCES · RESEARCH BRIEF 22 The lowest Phase 2 target group Dosage research Assigned amountTrial protocolGroup result
The lowest Phase 2 target group. Illustration for this research brief.

The lowest Phase 2 target group

The comparison describes an assigned group and a specific trial population. It does not determine what would happen with self-directed use or a different formulation.

How to interpret the evidence

Trace the number to the weight-results table and read the trial eligibility and safety sections alongside it.

This series reports assigned research arms for interpreting study results. Retatrutide is investigational, and clinical-trial amounts are not dosing instructions.

Sources